MR

Marsh & McLennan Companies, Inc.

MRSHFinancial ServicesNASDAQ

Insurance Brokers

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$26.98B
+10.3% YoY
Net Income
$4.16B
+2.5% YoY
EBITDA
$7.41B
+7.0% YoY
Free Cash Flow
$4.79B

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 19 RSI OversoldRSI 28.8, below 30, stock may be oversold
Aug 13 MACD Negative CrossoverHistogram -0.5498, negative momentum
About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. With a market capitalization of $88.64B, it sits in large-cap territory. The company operates through Risk and Insurance Services, and Consulting segments.

Where MRSH stands vs its 150-day and 200-day moving averages

As of the August 19, 2026 close, MRSH finished 7.06% above its 150-day moving average ($174.08) and 6.14% above its 200-day moving average ($175.59). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is MRSH overbought or oversold?

At the August 19, 2026 close, MRSH's RSI(14) was 28.8, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$88.64B
P/E (TTM)22.99
Fwd P/E16.28
EPS$8.08
Beta0.58
52W Change-7.4%
Dividend Yield2.10%
ROE25.9%
Analysis

The company holds $1.70B in cash, though total debt stands at $22.38B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $4.79B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 25.9% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $20.72B (2022) to $26.98B (2025), reflecting a 30% increase over the period.

With a beta below 0.7, Marsh & McLennan Companies, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Marsh & McLennan Companies, Inc.'s trajectory.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms